Skip to main content
. 2016 Jul 20;23:54. doi: 10.1186/s12929-016-0272-1

Fig. 2.

Fig. 2

Putative RIP based conjugates. a ImmunoRIPs obtained fusing RIPs to antibody (left) or minibody, as scFv (right). b Alternative bioconiujates obtained fusing RIPs to receptors (left), cellular ligands (center) and protease inhibitors (right)